Metronidazole

Print/View PDF

Sign in to continue reading this article

Not registered? Create an account for free to read full articles on www.veterinaryteambrief.com.

To access full articles on www.veterinaryteambrief.com, please sign in below.

Busy? Sign in Faster. Sign into www.veterinaryteambrief.com with your social media account.

Antibiotic, Antiprotozoal (Systemic Drug)

Prescriber Highlights

  • Injectable and oral antibacterial and antiprotozoal agent
  • Main side effects include neurologic disorders, lethargy, weakness, hepatotoxicity
  • Bitter tasting; may be more palatable when compounded

Uses, Indications

  • Used for treatment of Giardia spp in both dogs and cats, in addition to several other parasitic infections (eg, trichomonads, Balantidium coli) and anaerobic enteric and systemic infections 
  • Commonly used for peri-operative surgical prophylaxis when anaerobic infections (eg, colon, periodontal) are likely
  • Has some inhibitory actions on cell-mediated immunity that may play a role in its use for treatment of inflammatory bowel disease

Contraindications, Precautions, Warnings

  • Contraindications

Patients with a history of hypersensitivity to metronidazole or nitroimidazole derivatives

  • Precautions

Not recommended for use in severely debilitated, pregnant, or nursing patients; use with caution in patients with hepatic dysfunction

  • Warnings

Total daily dose should not exceed 65 mg/kg because of risk for neurotoxicity

Side Effects

  • Neurologic disorders, lethargy, weakness, neutropenia, hepatotoxicity, hematuria, nausea, anorexia, vomiting, and diarrhea have been reported in dogs
  • Neurologic toxicity in dogs may occur with acute high doses but is more common with chronic moderate- to high-dose therapy
  • Vomiting, inappetence, and hepatotoxicity can occur in cats undergoing metronidazole therapy 
  • Central nervous toxicity, although rare, can also occur in cats

Drug Interactions

  • Cimetidine may decrease the metabolism of metronidazole, increasing the possibility of dose-related side effects
  • Cyclosporine levels may increase when combined with metronidazole therapy
  • Fluorouracil (5-FU) may result in increased 5-FU levels and possible toxicity
  • Phenobarbital or phenytoin may increase the metabolism of metronidazole, decreasing blood levels
  • Metronidazole may prolong prothrombin time in patients receiving warfarin or other coumarin anticoagulants

Monitoring

  • Clinical efficacy, side effects

Client Information

  • Clients should pay close attention to any neurologic abnormalities

Dosage Forms

  • Metronidazole oral tablets: 250 mg, 500 mg
  • Metronidazole oral solution: 5 mg/mL

Compiled and summarized from Plumb’s Veterinary Drugs by Shannon Palermo, VMD

Information about this drug was adapted from Plumb’s Veterinary Drugs. Further details and more therapeutics can be found with a subscription at plumbsveterinarydrugs.com.

Material from Veterinary Team Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.

Veterinary Team Brief delivers practical skills for team-based medicine—with clinical strategies for team training, peer-reviewed credibility, concise content, essential training modules, and easy-to-implement protocols. From the publisher of Clinician's Brief.